Back to All Events

MIP Diagnostics Ltd. CEO Dr. Adrian Kinkaid speaking at Healthcare Sensor Innovations 2019

  • Cambridge United Kingdom (map)

Join us for a discussion about Cardiac Troponin I NanoMIPs

Cardiac Troponin I (cTnI) is an established marker for the diagnosis of myocardial infarction. Many cTnI antibodies have been developed and market leading Abs arguably offer the best antibody performance possible. We have made molecularly imprinted polymers (nanoMIPs), sometimes called "plastic antibodies", which offer equivalent or better sensitivity and robustness.

Dr. Adrian Kinkaid will be presenting this nanoMIP data in “Robust And Sensitive Sensors For Cardiac Troponin I Based On NanoMIPs” . Let us know if you are interested in more information about our Troponin I MIPS at

Healthcare Sensor Innovations 2019  presented by IDTechEx is a conference and table-top exhibition focusing on the latest developments in the use of wearables and sensors in continuous monitoring of individuals and point-of-care diagnostics. If you would like to attend the conference registration can be found here. We look forward to seeing you there.

Earlier Event: August 6
AACC 2019